Curcumin compound reactivates Epstein–Barr virus, offering safer cancer therapy

A novel curcumin derivative, C210, activates the Epstein–Barr virus (EBV) lytic cycle without producing infectious virions by disrupting HSP90. This discovery opens avenues for safer EBV-positive cancer therapies.

Diabetes accelerates the onset of severe long-term conditions by 15-20 years, cutting life expectancy

A study in Nature Medicine reveals that diabetes accelerates the onset of multiple long-term conditions by 15-20 years, significantly reducing life expectancy in English adults.

August 5, 2024

CopilotIQ & Biofourmis Merge to Create AI-Driven Platform for In-Home Care

What You Should Know: – CopilotIQ, a health tech company focused on improving the lives of older adults with chronic conditions, and Biofourmis, a global

October 22, 2024

Asieris showcases Phase III win in treating precancerous cervical lesions – Pharmaceutical Technology

Share this article According to GlobalData, there will be 123,846 cervical cancer cases in the eight major markets (UK, US, France, Germany, Spain, Italy, Japan,

March 19, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.